BrightSpring’s Amedisys, LHC Acquisition Drove $79M In Q1 Revenue – Image for illustrative purposes only (Image credits: Pixabay)
BrightSpring Health Services posted net revenues of $3.614 billion in the first quarter, marking a 25.6% rise from the prior year. The standout performer proved to be the recent integration of Amedisys and LHC Group assets, which generated $79 million in revenue and about $9 million in adjusted EBITDA. Executives described the early results as a strong foundation during Friday’s earnings call, with projections for a $30 million EBITDA uplift in the first full year of ownership.
New Assets Deliver Immediate Financial Lift
The Amedisys and LHC Group branches quickly bolstered BrightSpring’s performance after closing. These assets not only added substantial revenue but also aligned with ongoing integration efforts across the platform. Leadership noted particular strength in home health admissions, which exceeded expectations for the acquired units.
John Rousseau, BrightSpring’s CEO, pointed to a tailwind in provider services during the call. “Provider [services] obviously had a bit of a tailwind from the closing of the home health branches,” he said. “But notwithstanding that, we saw really good growth. One of the reasons we had a little outperformance on the home health branches that were required was a step up in admissions.”
Home Health Drives Surge with Multiple Tailwinds
The home health segment led the charge, recording $266 million in revenue – a 49% increase year-over-year. This growth stemmed from several factors, including expanded average daily census, new agency openings, favorable Medicare Advantage contracts, and the influx from acquisitions. The segment’s average daily census reached 46,066 in the quarter.
Stakeholders in home health stand to benefit from these dynamics, as higher census levels signal sustained demand and operational scale. The integration process has already shown promise, setting the stage for further efficiencies. Company efforts continue to focus on blending the new branches seamlessly into existing operations.
Operational Tweaks and Efficiency Gains
BrightSpring pursued cost savings and technological upgrades throughout the quarter. A key move involved centralizing order intake for the Amedisys and LHC assets, which previously operated independently. Early feedback indicated tangible benefits from this consolidation.
“They were not centralized, and we’re seeing some real benefit there already out of the gates,” Rousseau remarked. The company also employs AI tools to streamline processes. These steps aim to enhance margins while supporting expansion in personal care and home health alike.
Financial Snapshot and Forward Momentum
Personal care contributed $102 million in Q1 revenue, up 4% from last year, thanks to steady growth in persons served and reliable operations. The segment assisted 16,079 individuals during the period. Medicare developments provided additional reassurance, with the 2026 home health base rate finalized at a 1.3% increase – or $220 million – far milder than the 6.4% cut initially proposed by CMS.
| Segment | Q1 2026 Revenue | YoY Growth |
|---|---|---|
| Home Health | $266 million | 49% |
| Personal Care | $102 million | 4% |
| Total Net Revenues | $3.614 billion | 25.6% |
BrightSpring plans to apply for CMS’s Long-term Enhanced ACO Design Model, with submissions due in May. On mergers and acquisitions, Rousseau outlined a measured strategy favoring geographic tuck-ins and mid-sized deals from $5 million to $10 million. These moves target licensure needs and market entry, while value-based care initiatives progress amid favorable rate adjustments.
As BrightSpring navigates integration and pursues disciplined growth, the Q1 results underscore resilience in home health and stability elsewhere. Investors and healthcare providers alike will watch how the $30 million EBITDA target materializes and whether Medicare tailwinds persist into 2026.
